Nu Skin Enterprises Updates Second-Quarter Results And Raises 2013 Guidance

 Nu Skin Enterprises Updates Second-Quarter Results And Raises 2013 Guidance

Company announces date for full second-quarter earnings

PR Newswire

PROVO, Utah, July 9, 2013

PROVO, Utah, July 9, 2013 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE:
NUS) today announced a significant increase to estimated revenue and earnings
per share for the second quarter of 2013. Revenue is now estimated to be about
$680 million, with estimated earnings per share of approximately $1.20.
Foreign currency fluctuations negatively impacted second-quarter revenue by
approximately 3 percent. Prior revenue guidance was $570 to $580 million,
with earnings per share guidance of $0.91 to $0.95.

Additionally, the company announced that it is increasing its full-year 2013
revenue guidance by $320 million to $2.83 to $2.86 billion, including a
negative 5 percent impact from foreign currency fluctuations. The company now
expects 2013 earnings to be $4.85 to $5.00 per share.

"Our second-quarter results reflect the strong momentum of our business,"
stated Truman Hunt, president and chief executive officer. "After a record
2012 that included impressive ageLOC product launches in the second quarter,
we continue to generate healthy gains throughout our global business,
particularly in the Greater China, North Asia and Americas regions.

"We look forward to sharing full second-quarter results with our shareholders
on Aug. 1 during our quarterly conference call. In addition, we will provide
updates on our expectations for the remainder of the year, which include the
limited-time introduction of our new ageLOC TR90 weight management system in
September and October. We continue to expect this product introduction to be
the largest in our history and anticipate a net impact of approximately $380
to $400 million from TR90 sales in the second half of the year," concluded
Hunt.

Nu Skin will release its full second-quarter 2013 results prior to the market
opening on Thursday, Aug. 1. The Nu Skin management team will host a
conference call with the investment community later that same day beginning at
11 a.m. (EDT). The webcast of the conference call, including the financial
information to be presented, will be available on the investor section of the
company's web site at www.nuskin.com. A replay of the webcast will be
available at the same location through Aug. 15, 2013.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its
comprehensive anti-aging product portfolio, independent business opportunity
and corporate social responsibility initiatives. The company's scientific
leadership in both skin care and nutrition has established Nu Skin as a
premier anti-aging company. The company's anti-aging products feature the new
ageLOC^® suite of products including the ageLOC^® R^2 nutritional supplement,
ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the
ageLOC^® Transformation daily skin care system. A global direct selling
company, Nu Skin operates in 53 markets worldwide and is traded on the New
York Stock Exchange under the symbol "NUS." More information is available at
http://www.nuskin.com.

Please Note: This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended that represent the
company's current expectations and beliefs. All statements other than
statements of historical fact are "forward-looking statements" for purposes of
federal and state securities laws and include, but are not limited to,
statements of management's expectations regarding the company's performance,
initiatives, strategies and new product introductions; statements of estimates
or projections regarding revenue, earnings per share, foreign currency impact
and other financial items; statements of belief; and statements of assumptions
underlying any of the foregoing. In some cases, you can identify these
statements by forward-looking words such as "believe," "expect," "project,"
"anticipate," "estimate," "intend," "plan," "targets," "likely," "will,"
"would," "could," "may," "might," the negative of these words and other
similar words.

The forward-looking statements and related assumptions involve risks and
uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed herein.
These risks and uncertainties include, but are not limited to, the following:

  oestimates and guidance concerning anticipated revenue, earnings per share
    and the impact of foreign currency are preliminary estimates, and actual
    results may differ from the estimates and guidance provided based on a
    number of factors, including higher than anticipated expenses, changes in
    reserves and other financial statement or audit adjustments;
  oany failure of current or planned initiatives or products to generate
    interest among distributors and customers and generate sponsoring and
    selling activities on a sustained basis;
  orisks related to accurately predicting, delivering or maintaining
    sufficient quantities of products to support our planned initiatives or
    launch strategies, including possible ingredient supply limitations;
  ochallenging economic conditions globally;
  orisk of foreign currency fluctuations and the currency translation impact
    on the company's business associated with these fluctuations;
  orisks associated with general inquiries and complaints to consumer
    protection agencies in Japan regarding the activities of some
    distributors;
  oregulatory risks associated with the company's products, which could
    require the company to modify its claims or inhibit the company's ability
    to import or continue selling a product in a market if it is determined to
    be a medical device or if it is unable to register the product in a timely
    manner under applicable regulatory requirements;
  ocontinued regulatory scrutiny and investigations in Mainland China, which
    have from time to time in the past, and could in the future, negatively
    impact the company's business, including the interruption of sales
    activities in stores, loss of licenses, and the imposition of fines;
  oadverse publicity related to the company's business, products, industry or
    any legal actions or complaints by distributors or others;
  oany prospective or retrospective increases in duties on the company's
    products imported into the company's markets outside of the United States
    and any adverse results of tax audits or unfavorable changes to tax laws
    in the company's various markets; and
  ocontinued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements
contained herein are further qualified by a detailed discussion of associated
risks set forth in the documents filed by the company with the Securities and
Exchange Commission. The forward-looking statements set forth the company's
beliefs as of the date that such information was first provided and the
company assumes no duty to update the forward-looking statements contained in
this release to reflect any change except as required by law.

SOURCE Nu Skin Enterprises, Inc.

Website: http://www.nuskinenterprises.com
Contact: Investors — Scott Pond (801) 345-2657, spond@nuskin.com, Media — Kara
Schneck (801) 345-2116, kschneck@nuskin.com